27 March 2024 in JPRAS Open
Simultaneous breast augmentation with mastopexy is growing in popularity. It is a complex procedure that can lead to post-operative complications, patient dissatisfaction, and increased risk of litigation. The aim of this study is to describe an approach for the inverted-T augmentation-mastopexy technique, which limits intraoperative modifications, minimizes errors, and decreases post-operative complications and patient dissatisfaction. The study included 107 patients with Regnault's grade I and II ptosis and severe pseudoptosis. All patients were marked according to our novel technique, Mastopexy Augmentation Made Applicable and Safer (MAMAS), and operated by a single surgeon. All patients underwent simultaneous breast augmentation with Siltex Mentor Round Silicone Gel breast implants and mastopexy. Pre-operatively and post-operatively, patients filled the BREAST-Q. The mean follow-up was 24 months. Hundred and seven women received treatment in this study. Sixteen presented with post-operative complications, eleven in the early stage of recovery, and five in the late stage. There were eight cases of minor wound healing complications, all treated conservatively. Two cases of infection were noted, both were treated with oral antibiotics. One patient experienced post-operative bleeding after 13 days, which required surgical revision. In the late stage of recovery, five cases of implant displacement occurred and required revision surgery. No cases of capsular contracture and seromas were reported. According to Breast-Q, all patients were satisfied. MAMAS surgical technique, focusing on precise pre-operative marking for augmentation-mastopexy, is simple and easily reproducible. The procedure has a low complication rate and high patient satisfaction. It provides predictable and stable results over time.
15 April 2025 in JPRAS Open
Liposuction is a surgical method for fat aspiration, which reduces the amount of subcutaneous fat. Adipose tissue is important in regulating insulin sensitivity; however excess tissue accumulation, especially in the form of intra-abdominal fat, is associated with an increased risk of developing metabolic syndrome. Clinical findings associated with metabolic syndrome include central obesity, dyslipidemia, insulin resistance, hypertension, and atherosclerotic disease. Nevertheless, the long-term metabolic impact of liposuction is unclear. We aimed to analyze the effects of liposuction on the lipid profile, arterial blood pressure, and glucose metabolism in healthy women. Twelve patients who underwent liposuction were included in the study. The blood pressures, arterial blood pressure, and lipid profiles were measured before surgery and approximately 1 year after surgery. In addition, insulin sensitivities were measured using oral glucose tolerance test. In the long term, liposuction led to a slight reduction of body fat (p<0.05), but it did not affect the blood pressure or insulin sensitivity. Although the levels of total and low-density lipoprotein cholesterol were reduced, these decreases were not statistically significant. The results of the study are consistent with some of the published data, which indicated a slight decrease in blood lipids. Small-volume liposuction does not appear to induce significant metabolic changes. A larger cohort and longer follow-ups are needed to evaluate the effects on the lipid profile, blood pressure, and glucose metabolism of the patients being studied.
20 November 2025 in Archives of Plastic Surgery
Galactorrhea is a rare but well-described complication following aesthetic breast surgery. Augmentation with mastopexy is a procedure that combines breast tissue reduction with volume augmentation; however, only few cases of galactorrhea were described following this procedure. This report concerns three cases of galactorrhea after augmentation with mastopexy provided by two surgeons (J.P. and M.P.). Patients did not report any significant gynecological history, including a history of oral hormonal intake or galactorrhea in the past. All three patients underwent the dual plane breast augmentation together with the Wise-pattern breast lift. In two cases, the first symptoms occurred in the second week, and in one case in the third week after surgery, manifesting as breast pain and swelling. These clinical issues, accompanied by a small amount of white fluid secretion from the vertical scar, scar around nipple-areolar complex, and from the T-junction, were presented to the operating surgeons. Galactorrhea came to consideration after a negative microbiological examination. In two cases, galactorrhea was treated with oral dopaminergic medication cabergoline, with a good response to the therapy. All symptoms, including redness and pain, fully resolved at the 21st postoperative day without the necessity of surgical revision. One patient with bilateral secretion was treated by early operative revision. In the following days, secretion ceased, and after drain removal, further complications did not occur. Aesthetic results after 12 months were satisfactory in all patients. In conclusion, galactorrhea is a rare but significant complication of any mammaplasty surgery. Untreated secretion may lead to severe complications; however, early recognition and treatment may lead to good results and patient satisfaction.